|
|
|
Volumn 23, Issue 4, 2001, Pages 260-266
|
|
Evaluation of Napro-NU, A 2-chloroethylnitrosourea derivative of naphthalimide, as a rationally designed mixed-function anticancer agent
a
a
a
a
|
|
Author keywords
Alkylating activity; Anticancer agent; Nitrosourea; Screening
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
FLUOROURACIL;
NITROSOUREA DERIVATIVE;
ADVANCED CANCER;
ALKYLATION;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CANCER SURVIVAL;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SCREENING;
DRUG SYNTHESIS;
EHRLICH ASCITES TUMOR;
HEMATOPOIESIS;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IN VITRO STUDY;
IN VIVO STUDY;
KIDNEY DISEASE;
LIFESPAN;
LIVER DISEASE;
MOUSE;
NONHUMAN;
PROVOCATION TEST;
REPRODUCIBILITY;
SARCOMA 180;
|
|
EID: 0035696094
PISSN: 02043564
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (13)
|
